全文获取类型
收费全文 | 186714篇 |
免费 | 13348篇 |
国内免费 | 4313篇 |
专业分类
耳鼻咽喉 | 1360篇 |
儿科学 | 2538篇 |
妇产科学 | 3068篇 |
基础医学 | 23581篇 |
口腔科学 | 3379篇 |
临床医学 | 17488篇 |
内科学 | 23453篇 |
皮肤病学 | 2232篇 |
神经病学 | 12030篇 |
特种医学 | 6429篇 |
外国民族医学 | 1篇 |
外科学 | 15130篇 |
综合类 | 24127篇 |
现状与发展 | 21篇 |
一般理论 | 9篇 |
预防医学 | 15660篇 |
眼科学 | 2301篇 |
药学 | 25433篇 |
78篇 | |
中国医学 | 12686篇 |
肿瘤学 | 13371篇 |
出版年
2024年 | 466篇 |
2023年 | 2642篇 |
2022年 | 5642篇 |
2021年 | 7736篇 |
2020年 | 6608篇 |
2019年 | 6317篇 |
2018年 | 6319篇 |
2017年 | 6995篇 |
2016年 | 7085篇 |
2015年 | 6608篇 |
2014年 | 7479篇 |
2013年 | 11407篇 |
2012年 | 9210篇 |
2011年 | 11104篇 |
2010年 | 6989篇 |
2009年 | 7315篇 |
2008年 | 8749篇 |
2007年 | 9635篇 |
2006年 | 9045篇 |
2005年 | 8323篇 |
2004年 | 7149篇 |
2003年 | 6401篇 |
2002年 | 5058篇 |
2001年 | 4571篇 |
2000年 | 3826篇 |
1999年 | 3235篇 |
1998年 | 2535篇 |
1997年 | 2635篇 |
1996年 | 2394篇 |
1995年 | 2080篇 |
1994年 | 2019篇 |
1993年 | 1695篇 |
1992年 | 1558篇 |
1991年 | 1461篇 |
1990年 | 1260篇 |
1989年 | 1028篇 |
1988年 | 988篇 |
1987年 | 898篇 |
1986年 | 831篇 |
1985年 | 1207篇 |
1984年 | 969篇 |
1983年 | 735篇 |
1982年 | 754篇 |
1981年 | 620篇 |
1980年 | 601篇 |
1979年 | 477篇 |
1978年 | 297篇 |
1977年 | 259篇 |
1976年 | 243篇 |
1975年 | 186篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Megan L. Robbins Robert C. Wright Ana María López Karen Weihs 《Journal of psychosocial oncology》2019,37(2):160-177
AbstractObjectives: This study examined word use as an indicator of interpersonal positive reframing in daily conversations of couples coping with breast cancer and as a predictor of stress.Design: The Electronically Activated Recorder (EAR) and Linguistic Inquiry and Word Count (LIWC) were used to examine naturally occurring word use conceptually linked to positive reframing (positive emotion, negative emotion, and cognitive processing words).Sample: Fifty-two couples coping with breast cancer.Methods: Couples wore the EAR, a device participants wear, that audio-recorded over one weekend (>16,000 sound files), and completed self-reports of positive reframing (COPE) and stress (Perceived Stress Scale). LIWC, a software program, measured word use.Findings: Both partners’ word use (i.e., positive emotion and cognitive processing words) was associated with their own reported positive reframing, and spouses’ word use was also indicative of patients’ positive reframing. Results also revealed that, in general, words indicating positive reframing predicted lower levels of stress.Conclusions: Findings supported the hypothesis that partners—and particularly spouses of breast cancer patients—may assist each other’s coping by positively reframing the cancer experience and other negative experiences in conversation. 相似文献
42.
43.
Katherine M. Duszynski Nicole L. Pratt John W. Lynch Jesia G. Berry Michael S. Gold 《Vaccine》2019,37(2):280-288
Objective
To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.Design
Observational nationwide cohort study.Setting
Linked population data from the Australian Childhood Immunisation Register and National Death Index.Participants
Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.Main outcome measures
Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.Results
The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.Conclusion
Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality. 相似文献44.
45.
目的探讨喉癌患者血小板表面血小板膜糖蛋白Ⅱb/Ⅲa纤维蛋白原受体(PAC-1)、血小板P-选择素(CD62P)阳性表达率以及与患者临床病理特征和复发的关系。方法选取2014年1月~2015年12月间在我院耳鼻喉科手术治疗的116例喉癌患者,随访≥2年,并选取同期在我院体检的健康人群60例为对照组,采用流式细胞仪检测法检测外周血PAC-1和CD62P阳性率,并分析与临床病理特征、复发的关系。结果喉癌患者PAC-1和CD62P阳性表达率分别为(17.82±1.76)%和(22.87±3.13)%,明显高于健康人群(P<0.05);而且在喉癌患者PAC-1表达和CD62P表达呈正相关性(r=0.238,P<0.05)。T3-T4分期或N2-N3分期患者PAC-1和CD62P阳性表达率高于T1-T2分期或N0-N1分期患者(P<0.05)。另外远处转移组PAC-1和CD62P阳性表达率高于未发生转移组(P<0.05);随访期间有24例患者复发,复发率为20.69%。复发喉癌患者PAC-1、CD62P阳性表达率分别为(17.02±0.85)%和(21.84±1.17)%,明显高于未复发的喉癌患者(P<0.05)。经Logistics回归分析,PAC-1和CD62P是喉癌患者复发的独立危险因素(P<0.05)。结论PAC-1和CD62P阳性表达率与喉癌患者T分期、淋巴结转移和远处转移密切相关,同时可作为喉癌局部复发、区域淋巴结转移、远处转移的预测指标。 相似文献
46.
Micro‐evolution of the hepatitis B virus genome in hepatitis B e‐antigen‐positive carriers: Comparison of genotypes B and C at various immune stages 下载免费PDF全文
47.
48.
49.
50.
Treatment of posterior eye diseases is more challenging than the anterior segment ailments due to a series of anatomical barriers and physiological constraints confronted by drug delivery to the back of the eye. In recent years, concerted efforts in drug delivery have been made to prolong the residence time of drugs injected in the vitreous humor of the eye. Our previous studies demonstrated that poly(ortho ester) (POE) nanoparticles were biodegradable/biocompatible and were capable of long-term sustained release. The objective of the present study was to investigate the safety and localization of POE nanoparticles in New Zealand white rabbits and C57BL/6 mice after intravitreal administration for the treatment of chronic posterior ocular diseases. Two concentration levels of POE nanoparticles solution were chosen for intravitreal injection: 1.5?mg/ml and 10?mg/ml. Our results demonstrate that POE nanoparticles were distributed throughout the vitreous cavity by optical coherence tomography (OCT) examination 14 days post-intravitreal injection. Intraocular pressure was not changed from baseline. Inflammatory or adverse effects were undetectable by slit lamp biomicroscopy. Furthermore, we demonstrate that POE nanoparticles have negligible toxicity assessed at the cellular level evidenced by a lack of glia activation or apoptosis estimation after intravitreal injection. Collectively, POE nanoparticles are a novel and nontoxic as an ocular drug delivery system for the treatment of posterior ocular diseases. 相似文献